Edoxaban Impurity 12, identified by its CAS number 2803372-97-4, is a chemical compound associated with the anticoagulant drug edoxaban, which is used to prevent and treat thromboembolic disorders. While specific details about Edoxaban Impurity 12 may not be widely documented, impurities in pharmaceutical compounds typically arise during the synthesis or storage processes and can affect the efficacy and safety of the final product. Characteristics of such impurities often include variations in molecular structure, which may influence solubility, stability, and biological activity. Impurities are rigorously analyzed during drug development to ensure compliance with regulatory standards, as they can impact pharmacokinetics and pharmacodynamics. The identification and quantification of impurities like Edoxaban Impurity 12 are crucial for quality control in pharmaceutical manufacturing, ensuring that the final drug product is safe for patient use. Understanding the properties of such impurities is essential for maintaining the integrity of the therapeutic agent and for conducting further research into its effects and potential interactions.

Edoxaban Impurity 12

2803372-97-4: Edoxaban Impurity 12, identified by its CAS number 2803372-97-4, is a chemical compound associated with the anticoagulant drug edoxaban, which is used to prevent and treat thromboembolic disorders. While specific details about Edoxaban Impurity 12 may not be widely documented, impurities in pharmaceutical compounds typically arise during the synthesis or storage processes and can affect the efficacy and safety of the final product. Characteristics of such impurities often include variations in molecular structure, which may influence solubility, stability, and biological activity. Impurities are rigorously analyzed during drug development to ensure compliance with regulatory standards, as they can impact pharmacokinetics and pharmacodynamics. The identification and quantification of impurities like Edoxaban Impurity 12 are crucial for quality control in pharmaceutical manufacturing, ensuring that the final drug product is safe for patient use. Understanding the properties of such impurities is essential for maintaining the integrity of the therapeutic agent and for conducting further research into its effects and potential interactions.

CAS 2803372-97-4

Edoxaban Impurity 12

Edoxaban Impurity 156

Ref: 4Z-E-080176